长期评估米尔塔扎的安全性:基于FAERS数据库的现实世界药监测研究
1Department of Dermatology, Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, China.
PloS one
|March 6, 2026
概括
这项研究分析了21年的米尔塔扎安全数据,确定了已知的和意想不到的不良事件 (AE),如不安腿综合征. 这些发现支持米尔塔扎平.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学 临床药理学
- 精神病药物研究 精神病药物研究
背景情况:
- 米尔塔扎平是主要抑郁症 (MDD) 的常见治疗方法.
- 对于米尔塔扎的真实安全数据需要进一步评估.
- 了解米尔塔扎的安全性对于临床实践至关重要.
研究的目的:
- 系统评估米尔塔扎的长期安全性.
- 为了确定与米尔塔扎使用相关的潜在不良事件 (AE).
- 为了提供证据证明米尔塔扎的安全临床应用.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 数据库 (2004-2025) 中分析不良事件 (AE) 报告.
- 使用了四种不成比例分析方法:ROR,PRR,BCPNN和MGPS.
- 进行了敏感性分析,时间到发病 (TTO) 评估和韦布尔分布建模.
主要成果:
- 分析了17,953份AE报告;65.0%是由医疗保健专业人员提交的.
- 已知AE (昏昏欲睡,QT延长,自杀念头,肌肉分裂) 和意想不到的AE (不安腿综合征,神经乱性恶性综合征,梦) 确定了积极的安全信号.
- 59.52%的副作用发生在米尔塔扎治疗的第一个月内.
结论:
- 超过21年的真实世界药监数据证实了米尔塔沙的安全性.
- 确定了预期和意想不到的不良事件,突出了警的必要性.
- 这些发现支持米尔塔扎的安全临床使用,并强调持续安全监测的重要性.
相关概念视频
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K


